Oxford BioDynamics plc (OBD) Ordinary 0.p Shares
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Oxford BioDynamics upbeat on publication of EpiSwitch study
5 February 2025 12:34
(Sharecast News) - Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting...
-
Oxford BioDynamics raises £7.35m through placing, subscription and retail offer
17 January 2025 12:18
(Sharecast News) - Oxford BioDynamics, a precision clinical diagnostics company leveraging its 'EpiSwitch 3D' genomics platform, announced the successful completion of its fundraising initiative on...
-
Oxford Biodynamics CEO resigns as it seeks short-term funding
16 December 2024 10:50
(Sharecast News) - Clinical diagnostics specialist Oxford BioDynamics announced on Monday that Dr Jon Burrows had resigned from his positions as chief executive officer and board member, with immediate effect.
-
Director dealings: Oxford Biodynamics director lowers stake
20 October 2023 15:32
(Sharecast News) - Oxford Biodynamics revealed on Friday that Vulpes Testudo Fund had offloaded 777,000 ordinary shares in the AIM-listed biotechnology company.
-
Oxford BioDynamics secures US billing code for prostate test
3 October 2023 10:41
(Sharecast News) - Precision test developer Oxford BioDynamics has successfully secured a proprietary laboratory analysis (PLA) code from the American Medical Association's (AMA) Current Procedural...
-
Oxford Biodynamics first-half losses widen
30 May 2023 07:48
(Sharecast News) - Oxford BioDynamics reported revenue of £0.22m in its first half on Tuesday, up from £0.09m in the same period a year earlier.
-
Oxford Biodynamics raises £9.1m in placing
7 October 2022 12:57
(Sharecast News) - Biotech company Oxford BioDynamics said on Friday that it has conditionally raised around £9.1m in a placing to accelerate the commercialisation of a cancer test.
Company announcements Announcements
-
Holding(s) in Company
5 February 2025 14:13
Oxford Biodynamics
-
Holding(s) in Company
5 February 2025 14:11
Oxford Biodynamics
-
CRC Test Accurately Detects Cancer and Polyps
5 February 2025 07:00
Oxford Biodynamics
-
Holding(s) in Company
4 February 2025 14:38
Oxford Biodynamics
-
Result of GM and Director Dealings
31 January 2025 12:00
Oxford Biodynamics
-
CiRT: Real World Data Presented at ASCO-GI
23 January 2025 07:00
Oxford Biodynamics
-
Result of WRAP Retail Offer
17 January 2025 07:00
Oxford Biodynamics
-
Result of Placing and Subscription
15 January 2025 07:00
Oxford Biodynamics
-
WRAP Retail Offer
14 January 2025 17:09
Oxford Biodynamics
-
Proposed Fundraising
14 January 2025 16:35
Oxford Biodynamics
-
Issue of shares, Director / PDMR holdings and TVR
24 December 2024 07:00
Oxford Biodynamics
-
Shareholder Loan and Related Party Transaction
19 December 2024 14:41
Oxford Biodynamics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.